Efavirenz and cognition that matters
- PMID: 32379162
- DOI: 10.1097/QAD.0000000000002545
Efavirenz and cognition that matters
Comment on
-
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances.AIDS. 2020 Jan 1;34(1):53-61. doi: 10.1097/QAD.0000000000002377. AIDS. 2020. PMID: 31567160 Clinical Trial.
References
-
- Lapadula G, Bernasconi DP, Bai F, Foca E, Di Biagio A, Bonora S, et al. Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances. AIDS 2020; 34:53–61.
-
- Hakkers CS, Arends JE, van den Berk GE, Ensing MHM, Hooijenga I, Vink M, et al. Objective and subjective improvement of cognition. After discontinuing efavirenz in asymptomatic patients: a randomized controlled trial. J Acquir Immune Defic Syndr 2019; 80:e14–e22.
-
- Mayo NE, Brouillette MJ, Fellows LK. Understanding and optimizing brain health in HIV now: protocol for a longitudinal cohort study with multiple randomized controlled trials. BMC Neurol 2016; 16:8.
-
- Brouillette M-J, Fellows L, Brew B, Koski L, Cysique L, N. M. Head-to-head comparison of classifications of cognitive impairment for explaining presenteism among HIV+ workers in the Positive Brain Health Now (PBHN) aging Canadian cohort In: 10th International Workshop on HIV & Aging New-York, NY, USA; 2019.
-
- Brouillette M-J, Fellows L, Harris M, Smaill F, Smith G, Thomas R, et al. CSP11.01. Impact of Brain Health on Work Status and Productivity in People with HIV. In: The 28th Annual Canadian Conference on HIV/AIDS Research. Saskatoon, Saskatchewan, Canada; 2019.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
